SBC Medical Group Holdings Incorporated Common Stock (SBC) is a publicly traded Industrials sector company. As of May 20, 2026, SBC trades at $3.07 with a market cap of $294.40M and a P/E ratio of 7.19. SBC moved +4.15% today. Year to date, SBC is -33.26%; over the trailing twelve months it is -15.25%. Its 52-week range spans $2.62 to $10.25. Analyst consensus is buy with an average price target of $8.50. Rallies surfaces SBC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
SBC financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SBC recently traded at $3.07. Market cap is $294.40M. P/E ratio is 7.19. Revenue is $169.34M.
| Metric | Value |
|---|---|
| Price | $3.07 |
| Market Cap | $294.40M |
| P/E Ratio | 7.19 |
| EPS | $0.40 |
| Dividend Yield | 0.43% |
| 52-Week High | $10.25 |
| 52-Week Low | $2.62 |
| Volume | 112.61K |
| Avg Volume | 0 |
| Revenue (TTM) | $169.34M |
| Net Income | $40.88M |
| Gross Margin | 70.80% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $173.61M | $51.05M | $0.50 |
| 2024 | $205.42M | $46.69M | $0.48 |
2 analysts cover SBC: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.50.